Key facts
- This page summarizes Charles Cherington's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Sep 2023, 20:24.
Charles Cherington - 11 Sep 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 11 Sep 2023
- Net transaction value
- +$1,049,897
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2023, 20:24:50 UTC
- Prior SEC filing
- 25 Aug 2023
- Next SEC filing
- 20 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles Cherington
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles Cherington filed Form 4 for Comera Life Sciences Holdings, Inc. on 11 Sep 2023.
Change
- Previous filing in this sequence was filed on 25 Aug 2023.
- Current net transaction value: +$1,049,897.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMRA
transaction
Common Stock
Purchase
- Transaction value
- $1,049,897
- Shares
- +2,053,789
- Change %
- +55%
- Price
- $0.5112
- Shares after
- 5,813,650
- Date
- 11 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,268,761
- Date
- 11 Sep 2023
- Ownership
- By LLC
- Footnotes
- F2
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,328
- Date
- 11 Sep 2023
- Ownership
- By trust
- Footnotes
- F3
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,327
- Date
- 11 Sep 2023
- Ownership
- By trust
- Footnotes
- F4
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,328
- Date
- 11 Sep 2023
- Ownership
- By trust
- Footnotes
- F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMRA
transaction
Derivative
Warrants to Purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +5,134,474
- Change %
- Price
- $0.000000
- Shares after
- 5,134,474
- Date
- 11 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,134,474
- Exercise price
- $0.6135
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On September 11, 2023, pursuant to a private placement offering by the Issuer and following the receipt of stockholder approval, the Reporting Person acquired 2,053,789 shares of the Issuer's Common Stock and Warrants to purchase up to 5,134,474 shares of Common Stock. The combined purchase price per share of Common Stock and accompanying Warrant in the offering was $0.51125, with all of the purchase price allocated to the shares of Common Stock.
Footnote F2
Held by Cherington Holdings LLC, of which the reporting person is a partner.
Footnote F3
Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Benjamin P. Cherington, of which the reporting person is trustee.
Footnote F4
Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Cyrus B. Cherington, of which the reporting person is trustee.
Footnote F5
Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Henry S. Cherington, of which the reporting person is trustee.